Search Results - "Kaneto, Hideaki"

Refine Results
  1. 1

    Pancreatic β-cell glucose toxicity in type 2 diabetes mellitus by Kaneto, Hideaki

    Published in Current diabetes reviews (01-01-2015)
    “…Pancreatic β-cells secrete insulin when blood glucose levels become high. However, when β-cells are chronically exposed to hyperglycemia, their function…”
    Get more information
    Journal Article
  2. 2

    Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History by Kaneto, Hideaki, Kimura, Tomohiko, Obata, Atsushi, Shimoda, Masashi, Kaku, Kohei

    “…While there are various kinds of drugs for type 2 diabetes mellitus at present, in this review article, we focus on metformin which is an insulin sensitizer…”
    Get full text
    Journal Article
  3. 3

    Dulaglutide exerts beneficial anti atherosclerotic effects in ApoE knockout mice with diabetes: the earlier, the better by Sanada, Junpei, Obata, Atsushi, Obata, Yoshiyuki, Fushimi, Yoshiro, Shimoda, Masashi, Kohara, Kenji, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki

    Published in Scientific reports (14-01-2021)
    “…There has been no report about the mechanism for anti-atherosclerotic effects of dulaglutide (Dula) and/or about the difference of its effectiveness between in…”
    Get full text
    Journal Article
  4. 4

    Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis by Kaneto, Hideaki, Katakami, Naoto, Matsuhisa, Munehide, Matsuoka, Taka-aki

    Published in Mediators of Inflammation (01-01-2010)
    “…Type 2 diabetes is the most prevalent and serious metabolic disease all over the world, and its hallmarks are pancreatic β-cell dysfunction and insulin…”
    Get full text
    Journal Article
  5. 5

    Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus by Kimura, Tomohiko, Kaneto, Hideaki

    Published in Journal of diabetes investigation (01-02-2022)
    “…In the presence of metformin, the c‐Jun‐NH2‐terminal kinase and p38 pathways in β‐cells are inhibited, resulting in preserved aquaporin 7 expression and…”
    Get full text
    Journal Article
  6. 6

    Role of pancreatic transcription factors in maintenance of mature β-cell function by Kaneto, Hideaki, Matsuoka, Taka-aki

    “…A variety of pancreatic transcription factors including PDX-1 and MafA play crucial roles in the pancreas and function for the maintenance of mature β-cell…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Practical application of short-term intensive insulin therapy based on the concept of “treat to target” to reduce hypoglycaemia in routine clinical site by Nakashima, Koji, Okamura, Nobuhiro, Sanefuji, Hayato, Kaneto, Hideaki

    Published in Scientific reports (31-01-2020)
    “…The aim is to devise a new short-term intensive insulin therapy (N-SIIT) based on the concept of “treat to target” to avoid hypoglycaemia and was applied it to…”
    Get full text
    Journal Article
  9. 9

    Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice by Fushimi, Yoshiro, Obata, Atsushi, Sanada, Junpei, Nogami, Yuka, Ikeda, Tomoko, Yamasaki, Yuki, Obata, Yoshiyuki, Shimoda, Masashi, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki

    Published in Scientific reports (09-08-2021)
    “…Effects of combination therapy of dipeptidyl peptidase-4 (DPP-4) inhibitor and sodium-glucose co-transporter 2 (SGLT2) inhibitor on β-cells are still unclear,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class by Kaneto, Hideaki, Obata, Atsushi, Kimura, Tomohiko, Shimoda, Masashi, Kinoshita, Tomoe, Matsuoka, Taka-Aki, Kaku, Kohei

    “…Sodium-glucose co-transporter 2 (SGLT2) inhibitors facilitate urine glucose excretion by reducing glucose reabsorption, leading to ameliorate glycemic control…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Significance of body mass index for diagnosing sarcopenia is equivalent to slow gait speed in Japanese individuals with type 2 diabetes: Cross‐sectional study using outpatient clinical data by Nakanishi, Shuhei, Iwamoto, Masahiro, Shinohara, Hisanori, Iwamoto, Hideyuki, Kaneto, Hideaki

    Published in Journal of diabetes investigation (01-03-2021)
    “…Aims/Introduction This study examined the association between body mass index (BMI) and the risk of sarcopenia in Japanese type 2 diabetes patients. Materials…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Case Report: Markedly Long-Term Preservation of Pancreatic β-Cell Function in a Subject With Elderly Onset of Type 1 Diabetes Mellitus Showing High-Titer Autoimmune Antibodies for Over 4 Years by Shigemoto, Ryo, Anno, Takatoshi, Kawasaki, Fumiko, Kaku, Kohei, Kaneto, Hideaki

    Published in Frontiers in immunology (25-11-2021)
    “…Type 1 diabetes mellitus (T1DM) is mainly triggered by autoimmune β-cell destruction, usually leading to absolute insulin deficiency. Regarding the speed of…”
    Get full text
    Journal Article
  16. 16

    Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism by Nakashima, Koji, Kaneto, Hideaki, Shimoda, Masashi, Kimura, Tomohiko, Kaku, Kohei

    Published in Scientific reports (27-02-2018)
    “…Glucagon-like peptide-1 (GLP-1) stimulates insulin secretion from pancreatic beta cells and suppresses glucagon secretion from alpha cells. It remains…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Impact of sarcopenia on glycemic control and atherosclerosis in Japanese patients with type 2 diabetes: Cross‐sectional study using outpatient clinical data by Nakanishi, Shuhei, Iwamoto, Masahiro, Shinohara, Hisanori, Iwamoto, Hideyuki, Kaneto, Hideaki

    Published in Geriatrics & gerontology international (01-12-2020)
    “…Aim This study examined the association among sarcopenia and various surrogate markers of atherosclerosis in Japanese patients with type 2 diabetes (T2D)…”
    Get full text
    Journal Article
  19. 19

    Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation by Ikeda, Kenta, Morizane, Shin, Akagi, Takahiko, Hiramatsu-Asano, Sumie, Tachibana, Kota, Yahagi, Ayano, Iseki, Masanori, Kaneto, Hideaki, Wada, Jun, Ishihara, Katsuhiko, Morita, Yoshitaka, Mukai, Tomoyuki

    “…Patients with psoriasis are frequently complicated with metabolic syndrome; however, it is not fully understood how obesity and dyslipidemia contribute to the…”
    Get full text
    Journal Article
  20. 20